Literature DB >> 23123228

Predictors of progression to severe Alzheimer's disease in an incidence sample.

Peter V Rabins1, Sarah Schwartz, Betty S Black, Christopher Corcoran, Elizabeth Fauth, Michele Mielke, Jessica Christensen, Constantine Lyketsos, Joann Tschanz.   

Abstract

BACKGROUND: Little is known about factors influencing time to severe Alzheimer's disease (AD).
METHODS: Incident cases of AD in the cache county memory study were identified. Severe AD was defined as mini-mental state examination score of ≤10 or Clinical Dementia Rating Scale score of 3; cases with either mini-mental state examination score of ≥16 or clinical dementia rating <2 were not categorized as severe AD. Kaplan-Meier, log-rank tests, and Cox analyses were used to identify demographic, clinical, and genetic correlates of time to progression to severe AD.
RESULTS: Sixty-eight of 335 cases of incident AD developed severe dementia. In bivariate analyses, female gender, less than high school education, at least one clinically significant Neuropsychiatric Inventory domain at baseline, and the youngest and oldest ages exhibited shorter time to severe AD. In competing risk analysis, subjects with mild or at least one clinically significant neuropsychiatric inventory domain score, and subjects with worse health were more likely to progress to severe dementia or death.
CONCLUSIONS: Demographic and clinical variables predict progression to severe AD. Further study should examine whether these relationships are causal or correlational.
Copyright © 2013 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23123228      PMCID: PMC3791880          DOI: 10.1016/j.jalz.2012.01.003

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  13 in total

1.  APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

Authors:  J C Breitner; B W Wyse; J C Anthony; K A Welsh-Bohmer; D C Steffens; M C Norton; J T Tschanz; B L Plassman; M R Meyer; I Skoog; A Khachaturian
Journal:  Neurology       Date:  1999-07-22       Impact factor: 9.910

Review 2.  Does the chronic care model serve also as a template for improving prevention?

Authors:  R E Glasgow; C T Orleans; E H Wagner
Journal:  Milbank Q       Date:  2001       Impact factor: 4.911

3.  Incidence of AD may decline in the early 90s for men, later for women: The Cache County study.

Authors:  R A Miech; J C S Breitner; P P Zandi; A S Khachaturian; J C Anthony; L Mayer
Journal:  Neurology       Date:  2002-01-22       Impact factor: 9.910

4.  The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia.

Authors:  C G Lyketsos; E Galik; C Steele; M Steinberg; A Rosenblatt; A Warren; J M Sheppard; A Baker; J Brandt
Journal:  J Am Geriatr Soc       Date:  1999-04       Impact factor: 5.562

5.  The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.

Authors:  A Wimo; L Jönsson; A Gustavsson; D McDaid; K Ersek; J Georges; L Gulácsi; K Karpati; P Kenigsberg; H Valtonen
Journal:  Int J Geriatr Psychiatry       Date:  2010-10-28       Impact factor: 3.485

6.  The Mini-Mental State Examination.

Authors:  M F Folstein; L N Robins; J E Helzer
Journal:  Arch Gen Psychiatry       Date:  1983-07

7.  A new clinical scale for the staging of dementia.

Authors:  C P Hughes; L Berg; W L Danziger; L A Coben; R L Martin
Journal:  Br J Psychiatry       Date:  1982-06       Impact factor: 9.319

8.  Rates of progression in mild cognitive impairment and early Alzheimer's disease.

Authors:  Martha Storandt; Elizabeth A Grant; J Philip Miller; John C Morris
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

10.  Prevalence and treatment of neuropsychiatric symptoms in advanced dementia.

Authors:  Karan S Kverno; Peter V Rabins; David M Blass; Kathryn L Hicks; Betty S Black
Journal:  J Gerontol Nurs       Date:  2008-12       Impact factor: 1.254

View more
  23 in total

1.  Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.

Authors:  Jeannie-Marie S Leoutsakos; Sarah N Forrester; Constantine G Lyketsos; Gwenn S Smith
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).

Authors:  Nathan Herrmann; Tetsuhiro Harimoto; Robert Balshaw; Krista L Lanctôt
Journal:  Can J Psychiatry       Date:  2015-04       Impact factor: 4.356

3.  Neuropsychiatric symptoms in severe dementia: Associations with specific cognitive domains the Cache County Dementia Progression Study.

Authors:  William J Rozum; Bryce Cooley; Elizabeth Vernon; Joshua Matyi; JoAnn T Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2019-04-25       Impact factor: 3.485

4.  The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.

Authors:  Joann T Tschanz; Maria C Norton; Peter P Zandi; Constantine G Lyketsos
Journal:  Int Rev Psychiatry       Date:  2013-12

5.  Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study.

Authors:  Matthew E Peters; Sarah Schwartz; Dingfen Han; Peter V Rabins; Martin Steinberg; Joann T Tschanz; Constantine G Lyketsos
Journal:  Am J Psychiatry       Date:  2015-01-13       Impact factor: 18.112

Review 6.  Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?

Authors:  Damien Gallagher; Nathan Herrmann
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

7.  Caregiver-Care Recipient Relationship Closeness is Associated With Neuropsychiatric Symptoms in Dementia.

Authors:  Elizabeth K Vernon; Bryce Cooley; William Rozum; Gail B Rattinger; Stephanie Behrens; Joshua Matyi; Elizabeth Fauth; Constantine G Lyketsos; JoAnn T Tschanz
Journal:  Am J Geriatr Psychiatry       Date:  2018-12-01       Impact factor: 4.105

8.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 9.  Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.

Authors:  Laura N Gitlin; Katherine A Marx; Ian H Stanley; Bryan R Hansen; Kimberly S Van Haitsma
Journal:  Int Psychogeriatr       Date:  2014-08-06       Impact factor: 3.878

10.  Reducing neuropsychiatric symptoms in persons with dementia and associated burden in family caregivers using tailored activities: Design and methods of a randomized clinical trial.

Authors:  Laura N Gitlin; Catherine Verrier Piersol; Nancy Hodgson; Katherine Marx; David L Roth; Deidre Johnston; Quincy Samus; Laura Pizzi; Eric Jutkowitz; Constantine G Lyketsos
Journal:  Contemp Clin Trials       Date:  2016-06-21       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.